Suppr超能文献

新冠病毒检测呈阳性的患心脏病儿童及患先天性心脏病成人的预后:一项来自印度的多中心研究。

Outcome of COVID-19-positive children with heart disease and grown-ups with congenital heart disease: A multicentric study from India.

作者信息

Sachdeva Sakshi, Ramakrishnan Sivasubramanian, Choubey Mrigank, Koneti Nageswara Rao, Mani Kalaivani, Bakhru Shweta, Gupta Saurabh Kumar, Gangopadhyay Debasree, Kasturi Soumya, Mishra Jayashree, Nayak Hemant Kumar, Sivakumar Kothandam, Bobhate Prashant, Awasthy Neeraj, Das Debasis, Chakrabarti Manisha, Muthukumaran Chinnaswamy Sivaprakasam, Saileela Rajan, Dhulipudi Bhargavi, Chaudhary Shiv Kumar, Jayranganath Mahimarangaiah, Saxena Anita, Iyer Krishna Subramony, Kumar Raman Krishna, Kothari Shyam S, Kulkarni Snehal, Rao Suresh G

机构信息

Department of Cardiology, All India Institute of Medical Sciences, New Delhi, India.

Department of Pediatric Cardiology, Rainbow Children's Heart Institute, Hyderabad, Telangana, India.

出版信息

Ann Pediatr Cardiol. 2021 Jul-Sep;14(3):269-277. doi: 10.4103/apc.apc_134_21. Epub 2021 Aug 26.

Abstract

BACKGROUND

Outcome data of children with heart disease who acquired COVID-19 infection are limited.

AIMS

We sought to analyze outcome data and identify risk factors associated with mortality in children with heart disease and grown-ups with congenital heart disease (GUCH) who had a laboratory-confirmed COVID-19 infection.

SETTINGS AND DESIGN

This is a retrospective, multicentric, observational study.

MATERIALS AND METHODS

The study included children with heart disease and GUCH population, who presented with either symptomatic or asymptomatic COVID-19 infection to any of the participating centers. COVID-19-negative patients admitted to these centers constituted the control group.

RESULTS

From 24 pediatric cardiac centers across India, we included 94 patients with a median age of 12.5 (interquartile range 3-96) months and 49 (52.1%) patients were males. Majority (83 patients, 88.3%) were children. One-third of the patients ( = 31, 33.0%) had acyanotic congenital heart disease, and 41.5% ( = 39) were cyanotic, with > 80% of the patients being unoperated. Only 30 (31.9%) patients were symptomatic for COVID-19 infection, while the rest were incidentally detected positive on screening. A total of 13 patients died (case fatality rate: 13.8%). The in-hospital mortality rate among hospitalized patients was significantly higher among COVID-19-positive cases (13 of 48; 27.1%) as compared to COVID-negative admissions (9.2%) during the study period ( < 0.001). On multivariate analysis, the independent predictors of mortality among COVID-19-positive cases were severity of illness at admission (odds ratio [OR]: 535.7, 95% confidence interval [CI]: 6.9-41,605, = 0.005) and lower socioeconomic class (OR: 29.5, 95% CI: 1.1-814.7, = 0.046).

CONCLUSIONS

Children with heart disease are at a higher risk of death when they acquire COVID-19 infection. Systematic preventive measures and management strategies are needed for improving the outcomes.

摘要

背景

感染新型冠状病毒肺炎(COVID-19)的心脏病患儿的预后数据有限。

目的

我们试图分析预后数据,并确定实验室确诊感染COVID-19的心脏病患儿和先天性心脏病成人患者(GUCH)的死亡相关危险因素。

设置与设计

这是一项回顾性、多中心观察性研究。

材料与方法

该研究纳入了患有心脏病和GUCH的人群,他们在任何参与中心出现有症状或无症状的COVID-19感染。这些中心收治的COVID-19阴性患者构成对照组。

结果

我们纳入了来自印度24个儿科心脏中心的94例患者,中位年龄为12.5(四分位间距3 - 96)个月,49例(52.1%)为男性。大多数(83例,88.3%)是儿童。三分之一的患者(n = 31,33.0%)患有非青紫型先天性心脏病,41.5%(n = 39)为青紫型,超过80%的患者未接受手术。只有30例(31.9%)患者有COVID-19感染症状,其余患者在筛查时偶然检测为阳性。共有13例患者死亡(病死率:13.8%)。在研究期间,COVID-19阳性病例的住院患者院内死亡率(48例中的13例;27.1%)显著高于COVID阴性入院患者(9.2%)(P < 0.001)。多因素分析显示,COVID-19阳性病例中死亡的独立预测因素是入院时疾病严重程度(比值比[OR]:535.7,95%置信区间[CI]:6.9 - 41,605,P = 0.005)和社会经济阶层较低(OR:29.5,95% CI:1.1 - 814.7,P = 0.046)。

结论

心脏病患儿感染COVID-19时死亡风险更高。需要系统的预防措施和管理策略来改善预后。

相似文献

5
Impact of COVID-19 pandemic on pediatric cardiac services in India.新冠疫情对印度儿科心脏服务的影响。
Ann Pediatr Cardiol. 2021 Jul-Sep;14(3):260-268. doi: 10.4103/apc.apc_133_21. Epub 2021 Aug 26.
6
Validation of the grown-ups with congenital heart disease score.先天性心脏病成人评分的验证。
Heart. 2018 Jun;104(12):1019-1025. doi: 10.1136/heartjnl-2017-312275. Epub 2017 Dec 1.

引用本文的文献

5
COVID-19 Vaccines in the Pediatric Population: A Focus on Cardiac Patients.儿科人群中的新冠疫苗:关注心脏病患者
Can J Infect Dis Med Microbiol. 2024 May 15;2024:2667033. doi: 10.1155/2024/2667033. eCollection 2024.
6
Pediatric cardiology: In search for evidence.小儿心脏病学:探寻证据
Ann Pediatr Cardiol. 2023 Sep-Oct;16(5):311-315. doi: 10.4103/apc.apc_47_24. Epub 2024 Apr 1.
9
COVID-19 and heart disease in children: What have we learned?儿童的新冠病毒疾病与心脏病:我们了解到了什么?
Ann Pediatr Cardiol. 2023 Mar-Apr;16(2):81-86. doi: 10.4103/apc.apc_104_23. Epub 2023 Aug 16.

本文引用的文献

1
Impact of COVID-19 pandemic on pediatric cardiac services in India.新冠疫情对印度儿科心脏服务的影响。
Ann Pediatr Cardiol. 2021 Jul-Sep;14(3):260-268. doi: 10.4103/apc.apc_133_21. Epub 2021 Aug 26.
4
COVID-19 in Adults With Congenital Heart Disease.成人先天性心脏病患者中的 COVID-19。
J Am Coll Cardiol. 2021 Apr 6;77(13):1644-1655. doi: 10.1016/j.jacc.2021.02.023.
10
COVID-19 and congenital heart disease: a case series of nine children.COVID-19 与先天性心脏病:9 例患儿的病例系列。
World J Pediatr. 2021 Feb;17(1):71-78. doi: 10.1007/s12519-020-00397-7. Epub 2021 Jan 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验